Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Double-blind, Multi-centre, Active-Controlled (15, 30, and 45mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar (0.5 and 1 mg) in Patients with Type 2 Diabetes Mellitus https://kusajili.fr:443/Trial/F_aVDMP7Gk-UG1Z4rQ4yBQ%24a-double-blind-multi-centre-active-controlled-15-30-and-45mg-pioglitazone-long-term-extension-study-to-evaluate-the-safety-and-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message